Diagnostics News and Research RSS Feed - Diagnostics News and Research

CRISPR-Cas9 gene-editing technology targets every gene in the genome in animal cancer model

CRISPR-Cas9 gene-editing technology targets every gene in the genome in animal cancer model

For the first time, CRISPR-Cas9 gene-editing technology has been employed in a whole organism model to systematically target every gene in the genome. [More]
VolitionRx begins pilot study to assess feasibility of NuQ assays in detecting prostate cancer

VolitionRx begins pilot study to assess feasibility of NuQ assays in detecting prostate cancer

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for a broad range of cancer types and other conditions, today announced that it has initiated a pilot study to assess the feasibility of VolitionRx's proprietary NuQ assays in detecting prostate cancer. [More]
Phase III trial to test VSV-EBOV vaccine for preventing Ebola to be launched in Guinea

Phase III trial to test VSV-EBOV vaccine for preventing Ebola to be launched in Guinea

Based on promising data from initial clinical trials in late 2014, WHO with the Health Ministry of Guinea, Médecins Sans Frontières, Epicentre and The Norwegian Institute of Public Health, will launch a Phase III trial in Guinea on 7 March to test the VSV-EBOV vaccine for efficacy and effectiveness to prevent Ebola. [More]
Hitachi Aloka Medical announces release of Ultrasound Bone Densitometry System at ECR 2015

Hitachi Aloka Medical announces release of Ultrasound Bone Densitometry System at ECR 2015

Mr Minoru Yoshizumi, President of Hitachi Aloka Medical Ltd., Tokyo, Japan, is pleased to announce the release of EggQus, an extraordinary compact, portable Ultrasound Bone Densitometry System at the European Radiology Congress. Delegates will have the opportunity to see and test EggQus at the Hitachi Medical Systems booth 323, Expo C. [More]
Philips, UC Irvine partner to explore effectiveness of spectral imaging in breast density measurement

Philips, UC Irvine partner to explore effectiveness of spectral imaging in breast density measurement

Royal Philips today announced its collaboration with the University of California, Irvine, to explore how spectral breast imaging can improve breast density measurement, potentially aiding clinicians in more accurately gauging breast cancer risks and monitoring changes over time. [More]
GeneSight test better predicts antidepressant outcomes for patients with depression

GeneSight test better predicts antidepressant outcomes for patients with depression

The combinatorial, multi-gene GeneSight test has been found to better predict antidepressant treatment outcomes for patients with depression, and their use of health care resources, than any of the individual genes that comprise the test, according to a peer-reviewed analysis by investigators from the Mayo Clinic and Assurex Health, and published online by The Pharmacogenomics Journal. [More]
Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

Mayo Clinic and Gentag, Inc. have reached an agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes. [More]
Grifols, Alkahest sign definitive agreements

Grifols, Alkahest sign definitive agreements

Grifols, a global healthcare company and leading producer of plasma therapies, and Alkahest, a Redwood City, California based, privately held biopharmaceutical company founded upon the pioneering work of Dr. Tony Wyss-Coray and other leading scientists at Stanford University, today announced that they have signed definitive agreements whereby Grifols will make a major equity investment in Alkahest, and the companies will work together to develop novel plasma-based products for the treatment of cognitive decline in aging and disorders of the central nervous system (CNS), including Alzheimer's. [More]
Easy-to-obtain oral swab could be a game changer for TB control

Easy-to-obtain oral swab could be a game changer for TB control

Drawing inspiration from veterinary medicine, researchers at the University of Washington have helped developed a new prospective approach to diagnosing tuberculosis (TB) - easy-to-obtain oral swab samples, greatly improving on standard diagnostics. [More]
New pocket LED diagnostic sets from Welch Allyn

New pocket LED diagnostic sets from Welch Allyn

Exactly 100 years since Welch Allyn invented the world’s first self-illuminating hand-held ophthalmoscope, the company has launched a new Pocket LED set - proof of their continuing ability to keep pushing the boundaries with a winning combination of customer-pleasing quality, reliability and cutting edge technology. [More]
CEGIR launches patient contact registry for people with eosinophilic gastrointestinal diseases

CEGIR launches patient contact registry for people with eosinophilic gastrointestinal diseases

To coincide with Rare Disease Day 2015, the Consortium of Eosinophilic Gastrointestinal Disease Researchers today launched a patient contact registry for individuals with eosinophilic gastrointestinal diseases (EGID), a group of rare diseases. [More]
Routledge Journals' new special issue focuses on CFS, ME/CFS and ME research

Routledge Journals' new special issue focuses on CFS, ME/CFS and ME research

Routledge Journals is pleased to announce a new Special Issue from the Journal of Prevention & Intervention in the Community exploring topics and constructs that could help clarify uncertainties surrounding Chronic Fatigue Syndrome (CFS), Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), or Myalgic Encephalomyelitis (ME) research. [More]
Two cancer centres partner to advance personalized therapies against cancer

Two cancer centres partner to advance personalized therapies against cancer

Two internationally acclaimed cancer centres today announced a partnership to accelerate academic and clinical research to advance personalized, targeted therapies against cancer. [More]
MIT researchers devise new way to make complex emulsions

MIT researchers devise new way to make complex emulsions

MIT researchers have devised a new way to make complex liquid mixtures, known as emulsions, that could have many applications in drug delivery, sensing, cleaning up pollutants, and performing chemical reactions. [More]
New four-way collaboration aims to improve clinical decision-making in the treatment of colon cancer

New four-way collaboration aims to improve clinical decision-making in the treatment of colon cancer

EKF Diagnostics subsidiary, Selah Genomics, has announced a major, four-way collaboration with Greenville Health System (GHS, South Carolina), DecisionQ Corporation (Virginia), and BD (Becton Dickinson and Company, New Jersey). [More]
Sanofi announces FDA approval of Toujeo insulin to improve glycemic control in people with diabetes

Sanofi announces FDA approval of Toujeo insulin to improve glycemic control in people with diabetes

Sanofi announced today that the U.S. Food and Drug Administration approved Toujeo (insulin glargine [rDNA origin] injection, 300 U/mL), a once-daily long-acting basal insulin, to improve glycemic control in adults living with type 1 and type 2 diabetes. Toujeo is expected to be available in the U.S. at the beginning of Q2 2015. [More]
Simple paper strip test can rapidly diagnose Ebola

Simple paper strip test can rapidly diagnose Ebola

When diagnosing a case of Ebola, time is of the essence. However, existing diagnostic tests take at least a day or two to yield results, preventing health care workers from quickly determining whether a patient needs immediate treatment and isolation. [More]

All Fast-track diagnostics kits now available in 32 and 64 reaction sizes

Fast-track diagnostics, a global leader in the design, development and manufacture of infectious disease detection kits, will be delivering even more convenience and flexibility to customers in the way its kits are packaged and sold. From 1st March 2015, all Fast-track diagnostics kits will be sold in sizes of 32 and 64 reactions. [More]
bioLytical receives FDA approval for INSTI HIV Antibody Test

bioLytical receives FDA approval for INSTI HIV Antibody Test

bioLytical Laboratories Inc., a leading manufacturer of point-of-care rapid diagnostic tests, announced today that it has received U.S. Food and Drug Administration approval of its INSTI HIV Antibody Test for use in detecting antibodies to HIV type 2 (HIV-2). [More]
Agena releases MassARRAY 24-Well System for mass spectrometry-based genetic testing

Agena releases MassARRAY 24-Well System for mass spectrometry-based genetic testing

Agena Bioscience today released the MassARRAY 24-Well System for mass spectrometry-based genetic analysis, adding to its existing MassARRAY portfolio. The new 24-well format is tailored to smaller clinical testing laboratories requiring modest sample throughput, reduced initial hardware costs, and reduced time to result. [More]